MECHANISTIC PHARMACOKINETICS: COMPARTMENTAL MODELS

Slides:



Advertisements
Similar presentations
PHARMACOKINETIC.
Advertisements

Module 2 # 2 Pharmacokinetics absorption of drugs drugs can be given iv, im, sc, orally (po) if given parenterally, they should.
Nonlinear pharmacokinetics
Two-compartment model
Computational Biology, Part 18 Compartmental Analysis Robert F. Murphy Copyright  1996, All rights reserved.
One-compartment open model: Intravenous bolus administration
Week 3 - Biopharmaceutics and Pharmacokinetics
Practical Pharmacokinetics
Week 4 - Biopharmaceutics and Pharmacokinetics
Pharmacokinetics Based on the hypothesis that the action of a drug requires presence of a certain concentration in the fluid bathing the target tissue.
Dose Adjustment in Renal and Hepatic Disease
INTRAVENOUS INFUSION.
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
Quantitative Pharmacokinetics
The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida.
Nonlinear Pharmacokinetics
Pharmacokinetics Introduction
Valproic Acid Software and Presentation by: Ted, Rob, Jeff, Cassie, Tristan, Korin, Ron, Gabe, Matt, Judith, Lindsay.
Louisiana Tech University Ruston, LA Slide 1 Compartmental Models Juan M. Lopez BIEN 501 Friday, May 09, 2008.
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
PHARMACOKINETIC MODELS
Drug Administration Pharmacokinetic Phase (Time course of ADME processes) Absorption Distribution Pharmaceutical Phase Disintegration of the Dosage Form.
1 Exercise 15 Drug binding and investigation of the Michaelis Menten equation; pitfall of methods of linearisation.
The General Concepts of Pharmacokinetics and Pharmacodynamics
Noncompartmental Models. Introduction The noncompartmental approach for data analysis does not require any specific compartmental model for the system.
Clinical Pharmacokinetics Fundamental hypothesis: a relationship exists between the pharmacological or toxic response to a drug and the accessible concentration.
1. Fate of drugs in the body 1.1 absorption 1.2 distribution - volume of distribution 1.3 elimination - clearance 2. The half-life and its uses 3. Repeated.
Quantitative Pharmacokinetics
Plasma Protein Binding
INTRODUCTION CLINICAL PHARMACOKINETICS
Principles of pharmacokinetics Prof. Kršiak Department of Pharmacology, Third Faculty of Medicine, Charles University in Prague Cycle II, Subject: General.
Clarifications of Lecture #36- Drug Interactions I
The General Concepts of Pharmacokinetics and Pharmacodynamics
Do We Need to Optimize Protein Binding in Drug Discovery? NEDMDG Summary Meeting Xingrong Liu, Ph.D. Genentech.
Intrinsic Clearance Arthur G. Roberts. Hydrophobic vs. Hydrophilic more bound to plasma proteins more distributed throughout body more metabolized.
Pharmacokinetics 3rd Lecture
Source: Frank M. Balis Concentration and Effect vs. Time Conc./ Amount Effect [% of E MAX ] Time Central Compartment Peripheral Compartment Effect Compartment.
MS WinNonLin Project 9/28/15: PK Modeling I project due today.
Pharmacokienetic Principles (2): Distribution of Drugs
Physiology for Engineers
Pharmacology Phone Number: (203)
Population pharmacokinetic analysis of sorafenib in patients with solid tumours Serge Guzy.
Pharmacokinetics Tutoring
Chapter 7 COMPARTMENT MODELS
Lecture-8 Biopharmaceutics
Pharmacokinetics.
Dosing Regimen Concepts: 2-C, MM, Individualization principles
Anticonvulsants: Valproic acid
Distribution of protein therapeutics
Pharmacokinetics.
Kinetics, Modeling Oct 19, 2009 Casarett and Doull,
Kinetics, Modeling Oct 15, 2006 Casarett and Doull,
Pharmacokinetics: Drug Distribution and Drug Reservoirs
School of Pharmacy, University of Nizwa
Hawler Medical University
Selected Bioavailability and Pharmacokinetic Calculations
Biopharmaceutics Chapter-6
Linear vs Non-linear System
School of Pharmacy, University of Nizwa
Therapeutic Drug Monitoring chapter 1 part 1
Introduction to Pharmacology
Structure of the final PK/PD model.
Clinical Pharmacokinetics
Project #1: Drug Kinetics in Genetically Modified Mice
FDA Drug Approval Process
Q1: Drug A is a small and hydrophilic compound that distributes to extracellular fluids only. It has a volume of distribution of 5.6 L in a healthy 70-kg.
Distribution of protein therapeutics
Introduction to Pharmacology
Presentation transcript:

MECHANISTIC PHARMACOKINETICS: COMPARTMENTAL MODELS Lecture 6 MECHANISTIC PHARMACOKINETICS: COMPARTMENTAL MODELS Adv PK/PD 2006 Lecture 6

One Compartment Model Model =V1, k10 Adv PK/PD 2006 Lecture 6

Two compartment model Model =V1, k10, k12, k21 V2 = V1 k12 / k21 CL1 = V1 k10 CL2 = V1 k12 Adv PK/PD 2006 Lecture 6

Three compartment model Model =V1, k10, k12, k21, k13, k31 V2 = V1 k12 / k21 V3 = V1 k13 / k31 CL1 = V1 k10 CL2 = V1 k12 CL3 = V1 k13 Adv PK/PD 2006 Lecture 6

Two Compartment Model A2 A1 Adv PK/PD 2006 Lecture 6

Two Compartment Model Adv PK/PD 2006 Lecture 6

Two Compartment Model Adv PK/PD 2006 Lecture 6

Three Compartment Model Adv PK/PD 2006 Lecture 6

Three Compartment Model Adv PK/PD 2006 Lecture 6

Population Pharmacokinetics General rule for compartment models: Estimate the volumes and clearances These are NOT the underlying physical reality, by they come closer than other methods of parameterizing the model Volumes and clearances are the most likely to be normally distributed Adv PK/PD 2006 Lecture 6

Volume of Distribution at Steady State By definition, at steady state: C1=C2 = Css Adv PK/PD 2006 Lecture 6

Volume of Distribution at Steady State However, the statement C1 = C2 = Css only holds when elimination is from the central compartment If elimination occurs from compartment 2, then Vss is dependent on k20 and hence on clearance Adv PK/PD 2006 Lecture 6

Saturable Elimination Adv PK/PD 2006 Lecture 6

Saturable distribution Saturable plasma and/or tissue protein binding eg ACE inhibitors. CLu = unbound tissue clearance Cu = unbound concentration nPt = total number of binding sites in tissue Ka = association constant of bound drug Adv PK/PD 2006 Lecture 6

Saturable distribution Adv PK/PD 2006 Lecture 6